Skip to main content
. 2019 Aug 27;293(1):223–231. doi: 10.1148/radiol.2019190199

Table 5:

Summary of Overall Survival and PFS following Chemoembolization, Immunoembolization, Radioembolization, and Percutaneous Hepatic Perfusion

graphic file with name radiol.2019190199.tbl5.jpg

Note.—BCNU = 1,3-bis (2-chloroethyl)-1-nitrosourea, N/A = not available, PFS = progression-free survival from liver metastases.